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Abstract: (24650 words) 
Background: Alzheimer’s disease (AD) is associated with atrophy in entorhinal cortex (ERC), 
the hippocampus, and its subfields Cornu Ammonis 1 (CA1) and subiculum, which predict 
conversion from Mild Cognitive Impairment (MCI) to clinical AD. The stratum radiatum, 
lacunosum and moleculare (SRLM) are also important gateways involving ERC and CA1, 
which are affected by early AD pathology. 
Objective: To assess whether the SRLM is affected in MCI and AD. 
Methods: In this proof-of-concept study, 27 controls, 13 subjects with AD and 22 with MCI 
underwent 3T MRI. T1 maps were used for whole-hippocampal volumetry, T2 maps were 
segmented for hippocampal subfield areas, entorhinal cortex and subiculum thickness, and 
evaluated for SRLM integrity. 
Results: Significant CA1 atrophy and subiculum thinning were found in both AD and MCI 
compared to similarly aged controls. However, SRLM integrity was only significantly 
reduced in AD but not in MCI compared to controls. There were no significant differences in 
other hippocampal subfields (CA2, CA3/Dentate Gyrus) or ERC thickness between the 
groups. Finally, CA1 and CA3/DG areas and SRLM clarity were correlated with clinical and 
cognitive measurements of disease severity. 
Conclusion: Although this study was cross sectional, it suggests a progression of specific 
subfield changes from MCI to established AD that is associated with the reduced integrity of 
SRLM, which may reflect more widespread hippocampal involvement as the disease 
progresses and the relative preservation of SRLM in MCI. These results provide new MRI 
biomarkers for early detection and intervention, disease staging and understanding of the 
neurobiology in AD. 
Key words: AD, MCI, dementia, CA1, SRLM, subiculum, hippocampal, subfield, 
segmentation, MRI. 
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Introduction: 
Alzheimer's disease (AD) is the commonest cause of neurodegenerative dementia. A subset 
of patients with Mild Cognitive Impairment (MCI) are increasingly recognised, with 
symptomatic memory impairment but in whom the criteria for clinical diagnosis of AD are 
not met. These patients are at heightened risk of conversion to clinical AD, with conversion 
rate of approximately 10-15% per year compared to 1-2% of comparably aged cognitively 
normal individuals [1].  For early diagnosis and for monitoring in clinical trials, there is a 
pressing need for reliable and sensitive biomarkers that span the progression from early MCI 
to clinical AD. 
 
Brain imaging methods offer potential diagnostic and prognostic biomarkers in MCI and AD, 
especially where the imaging signals mirror the distribution of neuropathology. For example, 
numerous neuroimaging studies of AD have demonstrated whole-hippocampal atrophy 
versus cognitively normal older subjects [2]. However, whole-hippocampal atrophy is also 
found in other disorders including Parkinson’s disease [3], Dementia with Lewy Bodies 
(DLB) and vascular dementia [4], potentially limiting its utility as a specific biomarker in 
differential diagnosis, especially at early stages of MCI. 
 
There is evidence of differential effects of AD pathology among the different hippocampal 
subfields, with post mortem studies showing a hierarchical spread of amyloid and tau 
pathology beginning in the entorhinal (ERC) and perirhinal cortex, Cornu Ammonis (CA1) 
subfield and subiculum, and then stratum radiatum, lacunosum and moleculare (SRLM), 
followed by wider cortical dissemination [5,6]. It has been argued that such propagations are 
likely driven by transynaptic mechanisms observed from mouse models of AD [6,7] although 
selective vulnerability may also contribute. Sensitive brain imaging that reflects the 
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underlying pathology across medial temporal lobe structures would be a significant clinical 
advance from current whole-hippocampal measures.  
 
The SRLM contains numerous apical dendrites and axonal fasciculi parallel to the internal 
surface of the Cornu Ammonis, blending with the stratum moleculare of the Dentate Gyrus 
(DG). The SRLM acts as important gateways with two main glutamatergic excitatory inputs 
going to CA1 from CA3 and ERC [8], and also have a large population and variety of 
GABAergic interneurons that play a critical role in modulating the dynamic activity in 
hippocampus networks [9]. Thus SRLM, which are intimately involved in the pathways 
between CA1 and CA3/ERC, and between hippocampus and wider cortical areas, are 
important candidates as biomarkers of MCI and AD.  
 
In an early endeavour using a radial mapping technique on T1-weighted MRI, Apostolova 
and colleagues reported atrophy of the CA1 region and subiculum in AD [10,11]. An intrinsic 
limitation of the use of the radial mapping technique is that it only measures changes seen at 
the surface of the hippocampus, and as such is unable to either directly assess individual 
subfields or account for changes in deep structures like the DG, SRLM and CA3 subfields, of 
which a smaller proportion are directly visible on the surface of the hippocampus. Other 
methods include manual segmentation of high resolution T2 weighted MRI to directly 
quantify the hippocampal subfields [12,13,14]. Using this technique Mueller and colleagues 
[12] demonstrated that CA1 atrophy can occur in normal aging, but is markedly increased in 
AD. These findings are supported by Firbank et al [14] who showed that, in addition to 
significant CA1 and subiculum atrophy, there was also disproportionate atrophy of the ERC 
of AD subjects compared to similarly aged controls.  
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The possibility to detect brain structural changes before AD pathology becomes clinically 
severe has led to investigation of hippocampal changes in subjects with MCI. Apostolova et 
al [10] reported that amnestic MCI subjects had atrophy in CA1 and subiculum, albeit less 
pronounced than in those with AD, and that the degree of atrophy was predictive of 
conversion to AD [15]. Conversely, Mueller et al [16] showed that it was the CA1 to CA2 
transition zone that was atrophied in MCI subjects, and could differentiate MCI from controls. 
However, due to the variations in analysis techniques and heterogeneity of the samples, it 
remains unclear from the limited literature to date what is the precise nature of the changes in 
MCI, how these may change during progression to established AD, and whether they may be 
potentially useful diagnostic markers at different stages of the disease progression.  
 
We therefore tested the joint hypotheses that MRI can detect greater CA1 and subicular 
atrophy in AD, compared to controls, and that whilst subjects with MCI have CA1 volume 
loss, it would be intermediate between the AD and the control groups. Moreover, we 
predicted that the volume of the other subfields (CA2 and CA3/DG) would be relatively 
preserved, in both patient groups. Finally we used a visual rating system [14] to score the 
hypo-intense line within the hippocampus, which represents the highly myelinated fibres in 
the SRLM, as demonstrated by Coras et al [17], using a combination of ultra high field (7T) 
MRI and histological technique. We hypothesised that this imaging marker may demonstrate 
a reduced SRLM integrity in the AD but not in the MCI groups, indicating a more 
pronounced pathological changes in established AD than MCI.  
 
Materials and Methods: 
Subjects:  
We studied subjects with MCI (N = 22) and AD (N = 13) from secondary care memory 
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clinics and services in Cambridgeshire and the surrounding area, and aged-matched healthy 
controls (N = 27) recruited from the healthy partners of the patients and from advertising in 
the local area. Subjects were classified according to the current clinical diagnostic criteria for 
AD [18] or MCI [19]. All subjects underwent physical and cognitive assessment with the 
Mini Mental State Examination (MMSE) [20], Addenbrookes Cognitive Examination 
Revised (ACE-R) [21] and Rey Auditory Verbal Learning Test (RAVLT) [22]. Written 
consent was obtained from participants and their informants. Ethical approval for the study 
protocol was obtained from the National Research Ethics Service – East of England 
Committee.  
 
MRI Acquisition: 
All subjects underwent 3T structural MRI at the Cambridge Wolfson Brain Imaging Centre 
including volumetric T1-weighted (176 slices, 1.0 x 1.0 mm, 1.0 mm slice thickness, TR = 
2300ms, TE = 2.98ms, flip angle 9°) and two acquisitions of a high resolution hippocampal, 
T2-weighted coronal sequence (24 slices, 0.4 x 0.4mm, slice thickness 2.0 mm. TR = 6420ms; 
TE = 11ms; flip angle 160°) optimized to visualize hippocampal subfields and surrounding 
brain areas (Firbank et al., 2010). However, the T2 images have partial coverage due to the 
narrow field of view. 
 
Automated Hippocampal Volume Analysis: 
Brain tissue segmentation into grey matter (GM), white matter (WM) and cerebrospinal fluid 
(CSF) was performed using the T1-weighted volumetric images and the Gaussian mixture 
model in VBM toolbox of SPM8 (http://www.fil.ion.ucl.ac.uk/spm). The GM maps were then 
normalized using the DARTEL algorithm. Hippocampal region of interests (ROIs) were 
selected using AAL atlas in MNI space, and then inverse normalized back to each subject’s 
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native space using the participant-specific diffeomorphic parameters estimated from the 
previous DARTEL procedure. The resulting ROIs were also masked using the thresholded 
GM probability maps (at threshold p > 0.8) before the total hippocampal volume was 
calculated. Finally, in order to control for global volume effects, the hippocampal volumes 
were normalized by the estimated total intracranial volume (ICV). 
 
Hippocampal Subfields analysis:  
Hippocampal subfields were segmented manually using the high resolution (0.4mm x 0.4 mm) 
T2 weighted MRI data. A total of four five subjects (1 AD, 2 Control and 2 MCI) were 
excluded from the analysis due to motion artefact and distortion on the T2 high resolution 
images. (The scan quality was evaluated visually by raters in brain areas outside the 
hippocampus regions to avoid circularity in statistical inference),. As mentioned previously, 
in order to increase the signal to noise ratio we acquired two images for each subject and 
aligned them before averaging to produce a final image. The amount of head movement 
between the two acquisitions was estimated using the transformation matrix derived from the 
linear co-registration process between the two T2 images. We computed the norms from the 
motion parameters and compared them among the groups in order to assess whether there 
was systematic bias due to head motion. The averaged images for each subject were then 
analysed by two raters (L.H. and S.S.), blinded to the diagnosis and subject characteristics, 
using an established manual approach, in which the subfields CA1, CA2, CA3/DG were 
segmented on the 3 coronal slices directly posterior to the head of hippocampus [12,14]; see 
Figure 1. The areas of the traced structures were calculated and retained for subsequent 
analysis. 
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INSERT FIGURE 1 HERE 
 
The subiculum thickness (Figure 1) was measured at the point immediately before it joins the 
medial hippocampus on the three slices that had hippocampal traces made. The ERC 
thickness was measured at the same point on the first slice of the hippocampal tracings and 
then on the two slices anterior to this (in the hippocampal head) with the line drawn 
perpendicular to the inferior border of the ERC. Finally, we used a previously validated rating 
scale for visually scoring the clarity of the hypo intense line representing the SRLM (Figure 
2). The values for the subfield area, the ERC and subiculum thickness and the SRLM clarity 
score were averaged across the left and right hemispheres and the three image slices analysed. 
 
INSERT FIGURE 2 HERE 
 
Test-retest Reliability: 
We assessed the intra-rater reliability of the tracings by repeating the measurements with the 
same rater one month after the initial tracings. It was performed on a test dataset randomly 
subsampled 3 subjects from each group. As with the initial tracing, the rater was blinded to 
the diagnosis when repeating the procedure a month later. For inter-rater reliability, both 
raters traced the same test dataset of 9 subjects. We measured the percentage difference in 
measurements and Intraclass Correlation Coefficient (ICC), using a two way random model 
for absolute agreement of measurements.  
 
Statistics: 
We used SPSS 22 to test for normality of variables (Shapiro-Wilks test), and for variance 
(Levene’s test). Normally distributed variables were compared using ANOVA (age and total 
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ICV), non-parametric variables (years of education, MMSE and ACE-R score) were 
compared using Kruskal-Wallis test. Group comparisons of demographic variables were 
performed using Mann-Whitney U test. Chi-square test was used to test for sex differences 
between groups. Group difference in head motion was tested using ANOVA. We tested for 
between group differences in hippocampal subfields (CA1, CA2, CA3/DG), hippocampal 
volume, ERC and subiculum thickness and SRLM clarity using three way ANCOVA with 
age, total ICV and years of education as covariates and controlled for multiple comparisons 
using Bonferroni correction for seven measurements (hippocampal volume, CA1, CA2, 
CA3/DG, ERC and subiculum thickness and SRLM clarity) with an adjusted p-value 
threshold of 0.05/7 = 0.0071. Correlation between subfield and cognitive measures was 
adjusted for age, total ICV and years of education, and controlled for multiple comparisons 
using Bonferroni correction. 
 
Results: 
Subject Characteristics: 
Subject demographic data is summarised in Table 1. There were no significant differences 
between groups for gender. In addition to significantly reduced MMSE, ACE-R and RAVLT 
scores in the AD and MCI groups compared to controls, MCI subjects were older and had 
fewer years of education. There wais no significant group difference in head motion between 
the two T2 image acquisitions (p = 0.18). 
 
INSERT TABLE 1 HERE 
 
 
Automated hippocampal volumetry: 
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We found a significantly reduced hippocampal volume (Table 2) in AD subjects compared to 
controls (p < 0.001). MCI subjects demonstrated a reduced normalized hippocampal volume 
compared to controls (p = 0.002). MCI subjects although having intermediate atrophy 
compared to AD and controls, were not different from AD subjects (p = 0.254) (Figure 3A). 
This result remained unchanged after excluding the outlier in the MCI group (p = 0.152). 
 
INSERT TABLE 2 HERE 
 
 
INSERT FIGURE 3 HERE 
 
Manual Hippocampal Measurements: 
The reliability of intra- and inter-rater measurements was comparable to what is found in the 
literature [12,14], with differences in the CA1, CA2 and CA3/DG areas, SRLM clarity and 
subiculum and ERC thickness below 20%, which is regarded as a good consistency. The 
intra-rater reliability was generally better than the inter-rater reliability in terms of both 
percentage size differences and ICC; see Table 3. 
 
INSERT TABLE 3 HERE 
 
 
We found a significant atrophy of the CA1 (p = 0.002) and subiculum (p < 0.001) in the AD 
and MCI groups compared to controls. The MCI and AD group were not significantly 
different with respect to either CA1 area or subiculum thickness. We did not detect any group 
differences in other subfields: CA3/DG and CA2. There were no significant differences with 
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respect to thickness measurements of the ERC.  
 
For the hypo intense line clarity corresponding to the SRLM, we found a significant 
difference between the AD and MCI as well as AD and controls, with AD subjects having 
significantly reduced line clarity comparing to both MCI (p = 0.004) and controls (p < 0.001). 
There were no significant differences found between the MCI and control groups. Table 2 
and Figure 3 summarise the results for both manual and automated segmentation of the 
hippocampus.  
 
Correlation between MRI and Cognitive Measures: 
In subjects with AD and MCI, there was a significant correlation between MMSE and the 
CA3/DG areas (r = 0.571, p = 0.0015), and SRLM clarity (r = 0.508, p = 0.0049). ACE-R 
total score correlated with CA1 area (r = 0.502, p = 0.0065) and CA3/DG area (r = 0.534, p = 
0.0034). ACE-R memory sub-score correlated with CA3 area (r = 0.562, p = 0.0018) and 
normalized hippocampal GM volume (r = 0.501, p = 0.0066). No other significant correlate 
was found. 
 
Discussion: 
The key findings of this study were that: (i) both AD and MCI subjects displayed significant 
atrophy of CA1, subiculum and whole hippocampus volume compared to similarly aged 
controls, (ii) SRLM integrity was reduced in the AD group compared with similarly aged 
controls but not in MCI, suggesting that different subfields maybe affected at different stages 
of disease progression. 
 
The demonstration of CA1 atrophy in AD is consistent with the other studies utilising manual 
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tracing techniques [12,14], or automated radial distances [10,11]. CA1 atrophy in MCI has 
also been reported [10,15,16], and it has been shown to correlate with heightened risk of 
conversion from MCI to AD [15]. Although we did not detect any difference in the degree of 
atrophy between MCI and AD subjects, others have reported that the CA1 atrophy is less 
marked in MCI subjects [15]. Our finding of similar degrees of CA1 volume loss and 
subiculum thinning between AD and MCI groups suggests that although they may be a 
potential early biomarker for detecting AD at the MCI stage, it may not be a reliable imaging 
marker or reflect core underlying changes associated with the cognitive and functional 
transition from MCI to AD.  
 
In a recent feasibility in vivo study based on 7T MRI, Boutet et al [23] showed that coronal 
T2* weighted gradient echo images (0.3mm x 0.3mm) were able to separate hippocampal 
layers that are richer or poorer in neuronal bodies, in particular SRLM from its surrounding 
layers in CA and DG. Although at a relatively lower static field strength, our protocol has 
achieved comparable sensitivity as in 7T, therefore potentially providing a wider applicability 
in clinical settings where 3T MRI is safer and more readily available. The SRLM located at 
the transition zone of DG and CA1 subfields is rich in fibers and synapses, which provide 
intra-hippocampal connectivity between the DG, CA1 and CA3, as well as receiving inputs 
from the inferior temporal lobe and thalamic nucleus. There is evidence of early involvement 
of the SRLM in AD with loss of synapses [24,25] as well as a thinning of the SRLM 
detectable on MRI [23,26], which correlates strongly with memory impairment in AD 
subjects. This suggests a key role in the progression of AD [27], and possibly a sign of 
transition from MCI to AD, as supported by our findings. A key pathway with synapses 
projecting to the SRLM is the perforant pathway of the ERC [28], also affected early in the 
course of AD, with WM tract disruption detectable on MRI [29] as well as GM atrophy [14].  
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The observed reduction in SRLM clarity may reflect a combination of pathological factors 
including neuronal loss, increases in water content, iron deposition, gliosis, demyelination or 
other changes in tissue microstructure and fiber orientations in SRLM. This may be related to 
the spread of neurofibrillary tangle and microtubule-associated hyperphosphorylated tau 
pathology [23,30] involved in hippocampal inputs from ERC, and also wider cortical 
projections from the hippocampus [31,32] likely playing a key role in the propagation of AD 
pathology5. SRLM clarity was correlated with global measures of cognition (MMSE) 
suggesting that the integrity of SRLM, a hub region, may be a strong indicator of cognitive 
decline in AD. Interestingly, it has been found that the clinical symptoms of AD correlated 
strongly with synaptic dysfunctions rather than loss of the neurons [33]. Similarly, using the 
same visual rating scale, Firbank et al14 also showed decreased SRLM clarity when 
comparing AD to controls. When this was entered into a predictive model of line clarity in 
combination with subiculum thickness and whole hippocampal volume, it correctly classified 
81% of subjects and the MRI indices derived from high resolution imaging correlated with 
disease severity. Although the SRLM clarity rating could be confounded by head motion, we 
did not found find any significant group difference in movement between the two image 
acquisitions. The convergent results suggest that hippocampal subfield measures might 
indeed reflect disease progression from MCI to AD, although we recognise that our study is 
cross-sectional and not longitudinal. 
 
Other sub-fields may be pathologically implicated in AD progression, but imaging results are 
less consistent. For example, Mueller et al (2010), found that the CA1 to CA2 transition zone 
was the feature most able to discriminate MCI from controls. However, they used the width 
of the dorsal CA1 region to delineate this CA1-CA2 transition, and thus could in part be a 
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reflection of changes to that area of CA1. We found no correlation between the CA2 area and 
subject group mostly due to difference in methodology. We also found no significant 
differences between the CA3/DG regions, in keeping with some previous reports [12,13,14] 
but not others. For example, Yassa et al [34] reported atrophy in MCI subjects in the 
CA3/DG region, although this may be explained by the use of T1 weighted images, 
normalized and mapped to a template which included the CA2 sub-region as part of CA3/DG, 
and subsequently may not be reflective of the subfield boundaries used in this study.  
 
We also detected no difference in the width of the ERC, known from previous pathological 
studies to be affected early in AD [5].  Firbank et al [14] using the same technique, identified 
significant reductions in the thickness of the ERC and subiculum, and this atrophy has been 
demonstrated by other groups [12,13]. Although we detected a significant reduction in 
subiculum thickness in AD subjects compared to controls, consistent with the work of others 
[13,14], we highlight the comparatively poor reliability for ERC and subiculum thickness, 
emphasizing the difficulties in accurate detection of the subiculum and ERC morphology on 
in vivo MRI images, and for that reason we have interpreted these results with caution. We 
have previously highlighted the variability that is encountered when measuring these areas 
(area versus length measurement), but even adjusting the technique to encompass width 
measurements (as per Firbank et al [14]), rather than area or volume measurements, it is still 
difficult to reliably measure these two regions, or the CA2 total area due to the lack of 
contrasts and reliable radiological landmarks in separating these structures from their 
surrounding tissues even at high field strength [17]. 
 
There are several limitations to the current study. Although our patient cohorts were recruited 
according to strict clinical criteria, there has been no histological validation of these clinically 
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probable diagnoses. In addition, our MCI group was older and had fewer years of education 
than the AD group. Finally, the manual segmentation approach is time consuming and 
requires extensive training in order to achieve high reliability between raters. In a separate 
study by our group, hippocampal subfields were segmented using the automated FreeSurfer 
analysis for the same cohort [35]. In that study, we also found the same pattern of CA1, 
subiculum and whole hippocampal atrophy as the current study. However, we did not find 
any significant difference in SRLM between the AD and MCI groups perhaps due to the lack 
of sensitivity for FreeSurfer algorithm in quantifying this specific structure. 
 
Conclusion: 
We have found that CA1 atrophy and subiculum thinning is significantly greater in AD and 
MCI subjects than controls, but similar between MCI and AD, confirming previous studies 
indicating that CA1 and subiculum changes occur early in the disease process. Interestingly, 
only AD participants showed a reduction of SRLM clarity with no AD subjects scoring 
higher than 3 points, reflecting decreased integrity of the SRLM fiber network. This may be 
due to later changes associated with the transition from MCI to AD, and represents the wider 
spread of pathological change associated with the clinical expression of AD dementia [36]. 
Importantly, the measures of hippocampal subfield atrophy correlated with global cognitive 
function and memory performance, supporting their potential as biomarkers. Longitudinal 
imaging studies with our method would be useful to study disease progression and the impact 
of disease modifying interventions.  
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Table 1. Demographic, clinical and cognitive characteristics of the three study groups: 
 Controls (N=25) MCI (N=20) AD (N=12)  
Age 66.8 (6.2) [55-80] 75.2 (7.7) [62-90] 67.5 (9.1) [53-84] F = 7.78 p < 0.001 
Sex (F:M) 13:12 9:11 3:9 p = 0.3 
Years 
Education 
15.0 (2.7) [10-19] 12.6 (2.7) [10-18] 14.3 (3.4) [10-19] X2 = 6.6 p = 0.037 
MMSE 29.0 (1.0) [27-30] 27.3 (1.9) [24-30] 24.3 (3.3) [18-28] X2 = 23.4 p < 0.001ab 
ACE-R 
total 
93.1 (5.4) [79-99] 83.7 (7.6) [66-95] 72.6 (11.2) [51-89] X2 = 30.5 p < 0.001abc 
ACE-R 
Memory 
23.9 (2.3) [18-26] 17.0 (4.3) [9-24] 13.1 (3.7) [8-20] X2 = 36.5 p < 0.001ab 
RAVLT 9.0 (2.7) [3-15] 2.7 (2.7) [0-10] 1.2 (1.3) [0-4] X2 = 34.5 p < 0.001abc 
Head 
movement 
0.5 (0.4) [0.04-1.9] 0.6 (0.7) [0.07-2.8] 1.0 (1.2) [0.02-4.3] F = 1.79 p = 0.18 
 
Brackets represent standard deviation (SD) and [Range], F = ANOVA testwise statistic, X2 = 
Kruskal-Wallis test statistic. 
Abbreviations: MMSE = mini mental state examination, ACE-R = Addenbrookes Cognitive 
Examination – Revised, RAVLT = Rey Auditory Verbal Learning Test – delayed record 
score, head movement = norms from the image realignment parameters.  Post-hoc analysis 
(Mann-Whitney U test with Bonferroni correction): a = AD < Control; b = AD < MCI; c = 
MCI < Controls. 
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Table 2. Between-group differences in hippocampal measurements: 
 Controls (N=25) MCI (N=20) AD (N=12) ANCOVA F p 
CA1 area 
(mm2) 
23.8 (2.9) [22.6-25.0] 19.5 (3.5) [17.9-21.1] 19.7 (3.0) [17.8-21.6] F = 9.69 p < 0.001ac 
CA2 area 
(mm2) 
1.4 (0.2) [1.3-1.4] 1.4 (0.2) [1.3-1.5] 1.4 (0.3) [1.3-1.6] F = 0.52 p = 0.60 
CA3/DG area 
(mm2) 
18.0 (2.8) [16.9-19.2] 16.4 (3.3) [14.9-18.0] 16.4 (2.50) [14.9-18.0] F = 1.95 p = 0.15 
Subiculum 
thickness (mm) 
1.9 (0.2) [1.8-2.0] 1.7 (0.2) [1.6-1.8] 1.7 (0.2) [1.5-1.8] F = 11.25 p < 0.001ac 
ERC thickness 
(mm) 
2.3 (0.4) [2.2-2.5] 2.3 (0.5) [2.1-2.5] 2.1 (0.2) [2.0-2.3] F = 1.45 p = 0.24 
SRLM clarity 3.4 (0.8) [3.1-3.8] 2.4 (0.8) [2.1-2.8] 1.9 (0.6) [1.5-2.2] F = 16.82 p < 0.001ab 
Hippocampal 
GM Volume 
(cm3) 
3.3 (0.3) [3.2-3.5] 2.5 (0.8) [2.1-2.9] 2.4 (0.4) [2.1-2.6] F = 17.29 p < 0.001ac 
 
Brackets represent standard deviation (SD), [95% confidence interval], F = testwise statistic. 
ANCOVA adjusted for age, years of education and total intra-cranial volume with Bonferroni 
correction. Post-hoc analysis: a = AD < Control; b = AD < MCI; c = MCI < Controls. 
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Table 3. Reliability data: 
 CA1 CA2 CA3/DG Subiculum 
thickness 
ERC 
thickness 
SRLM 
clarity 
Inter-rater Reliability 
Percentage difference 
(%) 
11.9 11.7 12.8 11.6 9.2 18.9 
ICC (average measures) 0.775 0.798 0.629 0.751 0.572  
Significance p value < 0.001 < 0.001 0.018 < 0.001 0.01  
Weighted kappa value      0.527 
Intra-rater Reliability 
Percentage difference 
(%) 
8.3 6.5 9.3 8.3 4.0 12.7 
ICC (average measures) 0.83 0.832 0.813 0.839 0.559  
Significance p value < 0.001 0.002 0.005 0.004 0.107  
Weighted kappa value      0.722 
 
Reliability data total 9 samples (3 AD, 3 MCI, 3 Controls), percentage difference and ICC is 
a two-way random model testing absolute agreement. SRLM clarity reliability was computed 
using the weighted Cohen’s kappa instead of the ICC because SRLM clarity is an ordinal 
variable. 
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Figure 1 Manual segmentation of the hippocampal subfields: 
 
1. Subiculum, delineated at the medial border of the hippocampus, 2. Entorhinal cortex 
(ERC), measured perpendicular to the inferior border, 3. Cornu Ammonis 1 (CA1) subfield, 4. 
Cornu Ammonis 3/dentate gyrus (CA3/DG) subfield: the CA1-CA3 boundary is delineated 
using the clearly visible hypo intense line (left image) 5. Cornu Ammonis 2 (CA2) subfield, 
marked as the height of the CA1 subfield at the area approximate to the midpoint of 
horizontal axis 
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Figure 2 Visual clarity rating: 
 
Examples: A. Score 1/5: line is not visible across its entire course, B. Score 2/5: line is visible 
across less than half its course, C. Score 3/5: line is visible across half of its course, D. Score 
4/5: line is visible across over half its course, E. Score 5/5: line is visible across its entire 
course. 
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Figure 3 Beeswarm and box plots by group: 
 
Significant group differences in A. whole hippocampus GM volume (cm3), B. CA1 area 
(mm2), C. Subiculum thickness (mm), D. SRLM clarity. Note, the outlier in panel A was 
indicated by an arrow. 
 
  
 
 
